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(Normal) and over 140/90mmHg (High). Blood pressure was signiﬁcantly
increased with increased BMI. Urinary AGT, TBARS, and MCP-1 of high blood
pressure group were signiﬁcantly (po0.05) increased compared to those of
normal blood pressure. Urinary AGT has signiﬁcant positive correlation with
urinary TBARS, though it did not have a signiﬁcant correlation with MCP-1.
Estimated 24-h urinary Na excretion was signiﬁcantly increased with increased
urinary MCP-1, and TBARS. These results indicate that increase in blood
pressure is accompanied with RAS, oxidative stress, and inﬂammation in young
subjects, which is associated with salt intake.
http://dx.doi.org/10.1016/j.krcp.2012.04.542
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DIETARY INORGANIC PHOSPHORUS AND INTESTINAL
PEPTIDE ABSORPTION
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Both organic and inorganic phosphorus (Pi) are present in regularly
consumed foods such as meats, eggs, and dairy products. Pi is often
included in foods as an additive, as hidden phosphorus. The intestinal
peptide transporter PepT1 mediates protein absorption, which is disturbed
in renal insufﬁciency. In the present study, we examined the effects of
dietary Pi content on the intestinal peptide transport activity and
expression of PepT1. The following animal models were used: 1) 7-week-
old, male Wistar rats; and 2) rats that underwent 3/4 nephrectomy (3/4NR)
to induce chronic kidney disease (CKD). Rats were fed a normal-protein
(20%) diet containing low (0.02%), normal (0.6%) or high (1.2%) Pi levels.
Rats were also fed diets containing varying amounts of protein and either low
or normal Pi levels, as follows: 1) low Pi/normal protein, 2) low Pi/high (50%)
protein, 3) normal Pi/normal protein, and 4) normal Pi/high protein. Intestinal
peptide transport activity and PepT1 expression levels were signiﬁcantly
higher in CKD rats than in sham-operated controls. Compared with the
normal diet, the high-protein diet increased PepT1 expression in CKD rats.
Intestinal di-peptide transport activity and PepT1 protein levels did not
increase in rats fed the low-Pi/high-protein diet. In contrast, intestinal di-
peptide transport activity and PepT1 protein expression were markedly
increased in rats fed the normal-Pi/high-protein diet.
In conclusion, dietary Pi levels regulate intestinal peptide transport activity
via PepT1.
http://dx.doi.org/10.1016/j.krcp.2012.04.543
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EMPOWERING ESRD PATIENTS FOR ASSISTED SELF NUTRITIONAL CARE:
A SIMPLE BUT EFFECTIVE INTERVENTION FOR IMPROVING
NUTRITIONAL STATUS OF HEMODIALYSIS PATIENTS
Pratim Sengupta, Sumanta Biswas, Rumpa Nandy, AR Nandy
BelleVue Clinic, Kolkata, WestBengal, India
Protein energy wasting (PEW) is a prevalent problem among hemodialysis
patients. Lack of adherence to dietary principle based conventional diet charts
often fail to satisfy the nutritional requirements of the patients. We studied the
effect of simple nutritional training and empowerment of the patients to
formulate their own dietary menu in nutritional parameters of hemodialysis
patients in 68 stable non diabetic End stage renal disease (ESRD) patients who
are on maintenance hemodialysis. The factors which otherwise can affect the
nutritional status like sepsis, malignancy,tuberculosis were excluded. At the
beginning patient’s baseline nutritional status was assessed by anthropometric
measurements, Subjective Global Assessment and serum albumin level. Body
composition was assessed by linear regression equation (Durin-Womersley)
and Siri equation. The patients were divided in two comparable groups (Group-
A&B). In group A patients were prescribed individualized dietary prescription;
based on their nutritional allowance as per KDOQI guideline. In Group-B the
patients were initially made familiar with the dietary principals of the
commonly consumed food. Then they were trained by renal nutritionist by
study material, visual aid, and proportional food models and one to one
discussion to formulate a dietary menu, by these they were empowered to
formulate their own dietary menu. They were constantly assisted when faced
any problem. In both the group the nutritional parameters were reassessed
after three months of intervention. The results were analyzed statistically.
There was statistically signiﬁcant mean increment in the fat free mass index in
GroupB[0.8%(Gr.-A)Vs1.0%(Gr.-B),(po0.05)], the mean increment in the serum
albumin in the GroupB was also signiﬁcantly higher than GroupA[(0.6gm/
dl(Gr.A) Vs 0.9 gm/dl(Gr.B), po0.0]).Compared to Group-A there was
statistically favorable anthropometric changes in Group-B. In conclusion
patient empowerment and self nutrition care is proved to be an effective
intervention for improving nutritional status in hemodialysis patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.544
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Correction of metabolic acidosis is one of the goals of effective dialysis. The
KDOQI guidelines recommend serum bicarbonate 422meq/L irrespective of
dialysis modality. Since the measured bicarbonate reﬂects the steady state in
PD patients and the lowest inter-dialytic value in HD patients, we compared the
survival predictability of serum bicarbonate 10,400 PD and 110,951 HD patients
treated in DaVita facilities from 7/2001-6/2006 with follow-up through 6/2007.
PD patients were substantially less likely to have lower serum bicarbonate
(adjusted odds, o20meq/L, 0.40 (0.37–0.43); o22meq/L, 0.34 (0.33–0.36);
o24meq/L, 0.29 (0.28–0.30)). Unlike a reverse J-shaped relationship in HD, a
higher all-cause and cardiovascular mortality was seen only with time-
averaged serum bicarbonate o19meq/L in PD patients. In the entire study
population using HD patients with bicarbonate of 24-o25meq/L as reference,
a higher risk for all-cause mortality was observed for most patient sub-groups
with serum bicarbonate o22meq/L irrespective of dialysis modality (Figure).
In conclusion, the measured bicarbonate is signiﬁcantly higher in patients
treated with PD suggesting that the therapy provides a more stable correction
of metabolic acidosis than intermittent HD. In both HD and PD-treated patients,
serum bicarbonate o 22meq/L is associated with lower death risk. These data
provide support for KDOQI guidelines to achieve serum bicarbonate levels
422meq/L for all end-stage renal disease irrespective of dialysis modality.
http://dx.doi.org/10.1016/j.krcp.2012.04.545
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SERUM POTASSIUM AND CAUSE-SPECIFIC MORTALITY IN A LARGE
CONTEMPORARY PERITONEAL DIALYSIS COHORT
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Unlike hemodialysis (HD), peritoneal dialysis (PD) is a continuous therapy
and does not induce myocardial stunning. However, since the death risk in HD
and PD patients is similar we tested the hypothesis that low serum potassium
levels contribute more to the high cardiac risk seen with PD resulting in
cardiac risk equivalent to that seen with HD in patients treated in DaVita
facilities between 7/1/2001 through 06/30/2006 in the United States (PD,
10,468; HD, 111,651). PD patients were signiﬁcantly more likely to have
serum potassium o4 meq/L (adjusted odds ratio, 3.30 (3.05, 3.56)) than HD
patients and there was a U-shaped relationship between time-averaged
serum potassium and all-cause and cardiovascular mortality (adjusted
hazards ratio for all-cause mortality, potassium o3.5 meq/L, 1.51 (1.29,
1.76); Z5.5 meq/L, 1.52 (1.32, 1.75)). However, a higher risk for infection-
related mortality was seen only with low serum potassium. The population-
attributable risks for all-cause mortality for serum potassium o4.0 and
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